Work

Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer

Year: 2023

Type: review

Source: Pharmacology & Therapeutics

DOI: 10.1016/j.pharmthera.2023.108414

Authors: Mélanie A. Dacheux, Derek D. Norman, Gábor J. Tigyi, Sue Chin Lee

Institution: University of Tennessee Health Science Center

Language: English

Topic: Sphingolipid Metabolism and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: University of Tennessee, William and Ella Owens Medical Research Foundation, National Cancer Institute

Awards: Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis, G1355934732, G8997078787, Small molecule enhancers of tumor immunity targeting the LPA5 GPCR

OpenAlex ID: W4365457915

FWCI: 0.515

Cites: 154

Cited by: 20

Related to: 10